SCHOTT Pharma AG/OS/Call [28]/HSBC

Product class

Warrant - Classic

Last exchange day

18/12/2029

Performance (1M)

71.43%

Basis price

28.0000 [EUR]

Cap

- []

Leverage

3.95

Delta

0.55

Agio p.a. in %

61.56 %

Implicit volatility

46.95 %

SCHOTT Pharma AG ISIN: DE000A3ENQ51
20.45 / 20.50 | 0.25 (1.238%)Bid/Ask| Change

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.46 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 08:42:48 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.460.46
PREV. DAY'S PRICE0.48 (07/21)
CHANGE DAY BEFORE
-0.02
-4.17 %
52 WEEK HIGH / LOW (-) (-)

Indicators

TIME OF CALCULATION
16:59:39 PM (07/22/2026)
AGIO P.A. IN %
61.56 %
LEVERAGE
3.95
DELTA
0.55
IMPLICIT VOLATILITY
46.95 %
OMEGA
2.17
THETA
-0.02
VEGA
0.01

Master Data

WKN
HM1R90
ISIN
DE000HM1R901
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Leverage Product
PRODUCT CLASS
Warrant - Classic
PRODUCT NAME
Aktien-Optionsschein
ISSUER
HSBC Trinkaus & Burkhardt GmbH
TRADING SEGMENT
EUWAX
OPTION TYPE
call
UNDERLYING
SCHOTT PHARMA AG & CO. KGAA NPV
BASIS PRICE
28.0000 [EUR]
CAP
- []
KNOCKIN LEVEL
- [-]
RANGE
- - -
MULTIPLIER
0.10
EXERCISE TYPE
American
TRADING CURRENCY
Euro
NOMINAL CURRENCY
EUR
SETTLEMENT CURRENCY
Euro
SMALLEST TRADABLE UNIT
1.00
MINIMUM QUOTATION EUR
3,000.00
MINIMUM QUOTATION UNITS
10,000.00
LAST VALUATION DAY
19/12/2029
PAYMENT DATE
28/12/2029
FIRST EXCHANGE DAY
22/01/2026
LAST EXCHANGE DAY
18/12/2029
TRADING HOURS
08:00:00 AM - 10:00:00 PM
QUOTATION
fortlaufende Auktion
ISSUE VOLUME
20,000,000
QUANTO
No

Underlying

WKNA3ENQ5
ISIN
DE000A3ENQ51
SYMBOL
1SXP
NOMINAL CURRENCY
Euro
TYPE OF UNDERLYING
Equity
COUNTRY OF THE HOME STOCK EXCHANGE
Germany

Issuer

NAME
HSBC Trinkaus & Burkhardt GmbH
ADDRESS
HSBC Trinkaus & Burkhardt GmbH Derivatives Public Distribution Hansaallee 3 40549 Düsseldorf Deutschland
EMAIL ADDRESS
zertifikate@hsbc.de
SERVICE PHONE NUMBER
0800 4000910 (Germany only)
URLhttp://www.hsbc-zertifikate.de/

Product Description

This (call) warrant is linked to SCHOTT Pharma AG, the underlying instrument, and has a term ending on December 28, 2029. This is a leveraged product, where the investor participates disproportionately in the positive and negative performance of the underlying. The investor has the right to exercise throughout the term of the warrant. Upon exercise, the redemption amount is calculated as the difference between the price of the underlying and the strike price, adjusted for the multiplier of 0.10. Exercise occurs automatically at the end of the term. If, at that point in time, the price of the underlying is below the strike price, the product will expire worthless.